NYSE · Healthcare
AECOM (ACM)
As-reported financials and recent SEC filings for AECOM, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$16.14B
Net income
$561.8M
Net margin
3.5%
Diluted EPS
$4.21
ROE
20.8%
P/E (TTM)
14.8×
Market cap
$9.13B
Debt / equity
1.0×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $16.14B | $16.11B | $14.38B | $13.15B | $13.34B |
| Gross profit | $1.22B | $1.08B | $945.5M | $848.0M | $798.4M |
| Operating income | $1.03B | $827.4M | $324.1M | $646.8M | $629.6M |
| Net income | $561.8M | $402.3M | $55.3M | $310.6M | $173.2M |
| Diluted EPS | $4.21 | $2.95 | $0.39 | $2.18 | $1.16 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
11-K2026-06-26
View on EDGAR →42026-06-16
View on EDGAR →8-K2026-06-11
View on EDGAR →8-K2026-06-03
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →10-Q2026-05-12
View on EDGAR →8-K2026-05-11
View on EDGAR →Go deeper on ACM
Search AECOM’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.